Trade BTMD stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Biote Corp. Class A (BTMD) is trading at US$1.14, down 0.87% today as of Oct 12, 16:00 EDT. The company has a market capitalisation of US$46.17M. Over the past 52 weeks, BTMD has traded between US$1.06 and US$3.26. On Syfe you can trade BTMD with $0 commission and add it to your watchlist.
| Previous close | US$1.15 |
|---|---|
| Market cap | US$46.17M |
| P/E ratio | 5.95 |
| 52-week range | US$1.06 – US$3.26 |
| Volume | 63.33K |
| Exchange | US |
Biote Corp. Class A
biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. It delivers a comprehensive, end-to-end platform that provides practitioners with medical education, training and certification, practice management software, and digital and point-of-care marketing support. The company was founded in 2012 and is headquartered in Irving, TX.
Year: 2022
Truist Cuts Price Target on biote to $4 From $5, Keeps Buy Rating
Apr 16, 11:31 AM · MT Newswires
Biote Corp. Class A (BTMD) stock is trading at US$1.14, -0.87% from the previous close of US$1.15.
The market cap for Biote Corp. Class A (BTMD) stock is approximately US$46.17M.
The price-to-earnings ratio for Biote Corp. Class A (BTMD) is 5.95, based on the latest reported earnings.
The 52-week high for Biote Corp. Class A (BTMD) stock is US$3.26.
The 52-week low for Biote Corp. Class A (BTMD) stock is US$1.06.
Biote Corp. Class A (BTMD) does not currently pay a dividend.
Stay on top of BTMD
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
